Hour24 News
Sophisticated and simple
-
Overview: DARE-AF Trial Questions SGLT2 Inhibition After Ablation The latest findings from the DARE-AF trial suggest that dapagliflozin, an SGLT2 inhibitor, does not reduce the…
-
New Evidence Questions Long-Term Anticoagulation After AF Ablation For patients with atrial fibrillation (AF) who undergo successful ablation, clinicians often face the question: should a…
-
Groundbreaking Collaboration Brings AI-Powered Early Detection to the U.S. In a landmark move for preventive cardiology, Naples Community Hospital (NCH) has become the first hospital…
-
Understanding the Mortality Link: Polypharmacy in Heart Failure Polypharmacy, defined as the use of multiple medications, is common among patients with heart failure. A 2022…
